دورية أكاديمية
Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis.
| العنوان: | Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis. |
|---|---|
| المؤلفون: | Lentzsch, Suzanne1 (AUTHOR) sl3440@cumc.columbia.edu, Lagos, Galina G.1 (AUTHOR), Comenzo, Raymond L.2 (AUTHOR), Zonder, Jeffrey A.3 (AUTHOR), Pregja, Silva3 (AUTHOR), Osman, Keren4 (AUTHOR), Tsai, Wei-Yann1 (AUTHOR), Landau, Heather5 (AUTHOR), Sanchorawala, Vaishali6 (AUTHOR) |
| المصدر: | Amyloid. 2019 Supplement 1, Vol. 26, p113-114. 2p. |
| مصطلحات موضوعية: | *CARDIAC amyloidosis, *CLINICAL trial registries, *PROGRESSION-free survival, *DEXAMETHASONE, *CHRONIC lymphocytic leukemia |
| مستخلص: | Highlights from the article: Patients with relapsed or refractory AL amyloidosis have limited treatment options. Out of 23 patients with evaluable organ response, 5 of 13 patients had a renal response and 1 of 14 patients had cardiac response. In patients with refractory and/or relapsed AL amyloidosis with limited therapeutic options Ben/Dex is a viable treatment option that produced a substantial hematologic response and increased survival. |
| قاعدة البيانات: | Academic Search Index |
| ResultId |
1 |
|---|---|
| Header |
asx Academic Search Index 137680201 1187 6 Academic Journal academicJournal 1186.814453125 |
| PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=asx&AN=137680201&custid=s6537998&authtype=sso |
| FullText |
Array
(
[Availability] => 0
)
|
| Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis.
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Lentzsch%2C+Suzanne%22">Lentzsch, Suzanne</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> sl3440@cumc.columbia.edu</i><br /><searchLink fieldCode="AR" term="%22Lagos%2C+Galina+G%2E%22">Lagos, Galina G.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Comenzo%2C+Raymond+L%2E%22">Comenzo, Raymond L.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zonder%2C+Jeffrey+A%2E%22">Zonder, Jeffrey A.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Pregja%2C+Silva%22">Pregja, Silva</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Osman%2C+Keren%22">Osman, Keren</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tsai%2C+Wei-Yann%22">Tsai, Wei-Yann</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Landau%2C+Heather%22">Landau, Heather</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Sanchorawala%2C+Vaishali%22">Sanchorawala, Vaishali</searchLink><relatesTo>6</relatesTo> (AUTHOR) ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => <searchLink fieldCode="JN" term="%22Amyloid%22">Amyloid</searchLink>. 2019 Supplement 1, Vol. 26, p113-114. 2p. ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => *<searchLink fieldCode="DE" term="%22CARDIAC+amyloidosis%22">CARDIAC amyloidosis</searchLink><br />*<searchLink fieldCode="DE" term="%22CLINICAL+trial+registries%22">CLINICAL trial registries</searchLink><br />*<searchLink fieldCode="DE" term="%22PROGRESSION-free+survival%22">PROGRESSION-free survival</searchLink><br />*<searchLink fieldCode="DE" term="%22DEXAMETHASONE%22">DEXAMETHASONE</searchLink><br />*<searchLink fieldCode="DE" term="%22CHRONIC+lymphocytic+leukemia%22">CHRONIC lymphocytic leukemia</searchLink> ) Array ( [Name] => Abstract [Label] => Abstract [Group] => Ab [Data] => Highlights from the article: Patients with relapsed or refractory AL amyloidosis have limited treatment options. Out of 23 patients with evaluable organ response, 5 of 13 patients had a renal response and 1 of 14 patients had cardiac response. In patients with refractory and/or relapsed AL amyloidosis with limited therapeutic options Ben/Dex is a viable treatment option that produced a substantial hematologic response and increased survival. ) |
| RecordInfo |
Array
(
[BibEntity] => Array
(
[Identifiers] => Array
(
[0] => Array
(
[Type] => doi
[Value] => 10.1080/13506129.2019.1583200
)
)
[Languages] => Array
(
[0] => Array
(
[Code] => eng
[Text] => English
)
)
[PhysicalDescription] => Array
(
[Pagination] => Array
(
[PageCount] => 2
[StartPage] => 113
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => CARDIAC amyloidosis
[Type] => general
)
[1] => Array
(
[SubjectFull] => CLINICAL trial registries
[Type] => general
)
[2] => Array
(
[SubjectFull] => PROGRESSION-free survival
[Type] => general
)
[3] => Array
(
[SubjectFull] => DEXAMETHASONE
[Type] => general
)
[4] => Array
(
[SubjectFull] => CHRONIC lymphocytic leukemia
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Updated analysis of phase 2 study of bendamustine and dexamethasone in patients with relapsed/refractory systemic light chain (AL) amyloidosis.
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Lentzsch, Suzanne
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Lagos, Galina G.
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Comenzo, Raymond L.
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Zonder, Jeffrey A.
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Pregja, Silva
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Osman, Keren
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Tsai, Wei-Yann
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Landau, Heather
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Sanchorawala, Vaishali
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 02
[M] => 03
[Text] => 2019 Supplement 1
[Type] => published
[Y] => 2019
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-print
[Value] => 13506129
)
)
[Numbering] => Array
(
[0] => Array
(
[Type] => volume
[Value] => 26
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => Amyloid
[Type] => main
)
)
)
)
)
)
)
|
| IllustrationInfo |